StemCells (STEM) Misses Q3 EPS by 2c
Tweet
Share
E-mailGet Alerts STEM Hot Sheet
Price: $5.45 --0%
Financial Fact:
Research and development: 3.69M
Today's EPS Names:
VAXX, EGRX, AFIB, More
Financial Fact:
Research and development: 3.69M
Today's EPS Names:
VAXX, EGRX, AFIB, More
Join SI Premium – FREE
StemCells (NASDAQ: STEM) reported Q3 EPS of ($0.14), $0.02 worse than the analyst estimate of ($0.12). Revenue for the quarter came in at $883 million versus the consensus estimate of $220 million.
For earnings history and earnings-related data on StemCells (STEM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
- Hyperion DeFi (HYPD) Tops Q2 EPS by 57c
- Lumexa Imaging Holdings, Inc. (LMRI) Reports In-Line Q2 EPS; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
